Skip to main content
logo
Pharmsynthez (MOEX:LIFE)
Russia flag Russia · Delayed Price · Currency is RUB
4.505
+0.415 (10.15%)
At close: Jul 8, 2022

Pharmsynthez Financials Overview

Millions RUB. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period EndingJun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Revenue
203.98155.92247.35379.67438.33371.66
Revenue Growth
-10.04%-36.96%-34.85%-13.38%17.94%27.68%
Gross Profit
74.7239.414.9784.46157.39159.92
Operating Income
-125.29-170.8-303.5-125.96-227.55-147.36
Net Income
-194.73-253.91254.41-207.49-697.55-524.81
Earnings Per Share
-0.47-0.580.58-0.69-2.32-1.74
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period EndingJun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Cash & Investments
4.664.064.989.1715.310.41
Total Debt
409.38363.71365.02745.4708.21623.52
Net Cash (Debt)
-404.73-359.65-360.04-736.23-692.91-613.1
Net Cash Growth
------
Net Cash Per Share
-0.97-0.82-0.82-2.45-2.30-2.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period EndingJun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Operating Cash Flow
----3.35-62.7-232.76
Capital Expenditures
----3.47-0.28-9.68
Free Cash Flow
----6.82-62.97-242.45
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2022FY 2021FY 2020
Period EndingJun '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
Gross Margin
36.63%25.27%2.01%22.24%35.91%43.03%
Operating Margin
-61.42%-109.54%-122.70%-33.18%-51.91%-39.65%
Pretax Margin
-76.26%-133.91%4.12%-54.97%-167.32%-141.85%
Profit Margin
-95.46%-162.85%102.85%-54.65%-159.14%-141.21%
FCF Margin
----1.80%-14.37%-65.23%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2022FY 2021FY 2020
Period EndingAug '26 Dec '25 Dec '24 Dec '22 Dec '21 Dec '20
PE Ratio
--7.80---
PS Ratio
6.65-8.023.573.855.55